{
  "file": "Ba_20Dicko_20Oumar.pdf",
  "total_pages": 123,
  "pages_checked": 15,
  "pages_with_text": 15,
  "text_coverage_ratio": 1.0,
  "scanned_pdf": false,
  "abstract_fr": "RESUME ............................................................................................83 \n8. BIBLIOGRAPHIE",
  "abstract_en": null,
  "abstract_ar": null,
  "has_keywords_marker": true,
  "toc_items": [
    "1.  INTROD UCTION ............................................................................1",
    "2.  PATIENTS  ET METH ODE ..........................................................3",
    "2.1. PATI ENTS ...................................................................................4",
    "2.2. METHOD E...................................................................................6",
    "3. RESULTATS......................................................................................10",
    "3.1. DONNEES EPIDEMIOLOGI QUES ........................................11",
    "3.1.1. Fréque nce..........................................................................11",
    "3.1.2. Répar tition au cours de  l’année ........................................11",
    "3.1.3. Age....................................................................................12",
    "3.1.4. Sexe   ................................................................................13",
    "3.2 ANT ECEDEN TS ......................................................................14",
    "3.3. TEMPERAT URE A L’ADMISSION  ....................................14",
    "3.4. TYPE  DE CONVUL SION......................................................15",
    "3.5  BILAN  ETIOLO GIQUE DE LA  FIEVRE. ............................16",
    "3.5.1  Bilan  biologi que..............................................................17",
    "3.5.1.1 Bilan bact ériologi que .................................................17",
    "3.5.1.1.1. Ponction lombaire  (PL) ......................................17",
    "(ECBU)................................................................18",
    "3.5.1.1.3  Hémocu lture .......................................................18",
    "3.5.1.2 Bilan inflammatoire ..................................................18",
    "3.5.2  Bilan ra diologi que..........................................................19",
    "3.5.2 .1 Radiogra phie pulmonaire ........................................19",
    "3.5.2 .2 Tomodensito métrie (TDM) .....................................19",
    "3.5.2 .3 Echographie Trans. Fontanelle (ETF) .....................19",
    "3.5.3.  Autres  .............................................................................20",
    "3.6.  TRAITE MENT ..........................................................................21",
    "3.6.1 Traitement immédiat.............................................................21",
    "3.6.2. Traitement préventif ...........................................................22",
    "3.7.  EVOLUT ION ............................................................................23",
    "3.8. DU RÉE D’HOSPITAL ISATION .............................................24",
    "4. DISCU SSION.....................................................................................25",
    "4.1.  NOSOLO GIE ............................................................................26",
    "4.2.  PHYSIOPATH OLOGIE ...........................................................28",
    "4.3   ÉPIDEMIOLO GIE ....................................................................31",
    "4.4.  ANTECEDE NTS.......................................................................34",
    "CONVULSIONS FEBRILES ..................................................38",
    "4.6.   DIAG NOSTIC DIFFERENTIEL.............................................41",
    "4.7.   BI LAN  ETIOL OGIQUE .........................................................44",
    "4.8   TRAITEME NT .........................................................................56",
    "4.8.1. Traiteme nt immédiat ............................................................56",
    "4.8.2. Traiteme nt prév entif.............................................................60",
    "4.9. ÉVOLUTIO N ..............................................................................68",
    "4-9-1 Risque  immédiat ...................................................................68",
    "4-9-2 Risque de récurren ces ..........................................................69",
    "4- 9-3 Séquelles psychi ques ........................................................... 75",
    "4-9-4 Ep ilepsie sec ondaire  ............................................................76",
    "4- 10 Pronostic   ...............................................................................79",
    "5. CONCLU SION .................................................................................. 80",
    "6. RESUME ............................................................................................83"
  ],
  "toc_start_page": 3,
  "toc_end_page": 10,
  "references_count": 0
}